AXSOME THERAPEUTICS, INC. Operating Cash Flow
AXSOME THERAPEUTICS, INC. (AXSM) reported Operating Cash Flow of -$53.65 million for the 6-month period ending 2026-06-30, per its 10-Q filed 2026-08-10.
Financial Statements › Cash Flow › Operating Activities
us-gaap:NetCashProvidedByUsedInOperatingActivities · last filed 2026-08-10
- AXSOME THERAPEUTICS, INC. net cash provided by (used in) operating activities for the quarter ending 2026-06-30 was -$32.95M.
- AXSOME THERAPEUTICS, INC. net cash provided by (used in) operating activities for the quarter ending 2026-03-31 was -$20.70M.
- AXSOME THERAPEUTICS, INC. net cash provided by (used in) operating activities for the quarter ending 2025-12-31 was -$18.65M.
- AXSOME THERAPEUTICS, INC. net cash provided by (used in) operating activities for the quarter ending 2025-09-30 was $1.05M.
- AXSOME THERAPEUTICS, INC. net cash provided by (used in) operating activities for fiscal 2025 was -$93.41M.
- AXSOME THERAPEUTICS, INC. net cash provided by (used in) operating activities for fiscal 2024 was -$128.41M.
- AXSOME THERAPEUTICS, INC. net cash provided by (used in) operating activities for fiscal 2023 was -$145.08M.
- AXSOME THERAPEUTICS, INC. net cash provided by (used in) operating activities for fiscal 2022 was -$116.51M.
| Period end | Net Cash Provided by (Used in) Operating Activities 3 month | Net Cash Provided by (Used in) Operating Activities 3 month as first filed | Net Cash Provided by (Used in) Operating Activities 6 month | Net Cash Provided by (Used in) Operating Activities 6 month as first filed | Net Cash Provided by (Used in) Operating Activities 9 month | Net Cash Provided by (Used in) Operating Activities 9 month as first filed | Net Cash Provided by (Used in) Operating Activities 12 month | Net Cash Provided by (Used in) Operating Activities 12 month as first filed |
|---|---|---|---|---|---|---|---|---|
| 2026-06-30 | -$32.95M derived: 10-Q 6 month − 10-Q 3 month · filed 2026-08-10 | -$53.65M 10-Q · filed 2026-08-10 | -$72.31M derived: sum of 3 quarters · filed 2026-08-10 | -$71.26M derived: sum of 4 quarters · filed 2026-08-10 | ||||
| 2026-03-31 | -$20.70M 10-Q · filed 2026-05-04 | -$39.35M derived: sum of 2 quarters · filed 2026-05-04 | -$38.31M derived: sum of 3 quarters · filed 2026-05-04 | -$70.73M derived: sum of 4 quarters · filed 2026-08-10 | ||||
| 2025-12-31 | -$18.65M derived: 10-K 12 month − 10-Q 9 month · filed 2026-02-23 | -$17.61M derived: sum of 2 quarters · filed 2026-02-23 | -$50.03M derived: sum of 3 quarters · filed 2026-08-10 | -$93.41M 10-K · filed 2026-02-23 | ||||
| 2025-09-30 | $1.05M derived: 10-Q 9 month − 10-Q 6 month · filed 2025-11-03 | -$31.38M derived: sum of 2 quarters · filed 2026-08-10 | -$74.75M 10-Q · filed 2025-11-03 | -$100.95M derived: sum of 4 quarters · filed 2026-08-10 | ||||
| 2025-06-30 | -$32.42M derived: 10-Q 6 month − 10-Q 3 month · filed 2026-08-10 | -$75.80M 10-Q · filed 2026-08-10 | -$102.00M derived: sum of 3 quarters · filed 2026-08-10 | -$120.63M derived: sum of 4 quarters · filed 2026-08-10 | ||||
| 2025-03-31 | -$43.38M 10-Q · filed 2026-05-04 | -$69.58M derived: sum of 2 quarters · filed 2026-05-04 | -$88.21M derived: sum of 3 quarters · filed 2026-05-04 | -$118.32M derived: sum of 4 quarters · filed 2026-05-04 | ||||
| 2024-12-31 | -$26.20M derived: 10-K 12 month − 10-Q 9 month · filed 2026-02-23 | -$44.83M derived: sum of 2 quarters · filed 2026-02-23 | -$74.94M derived: sum of 3 quarters · filed 2026-02-23 | -$128.41M 10-K · filed 2026-02-23 | ||||
| 2024-09-30 | -$18.63M derived: 10-Q 9 month − 10-Q 6 month · filed 2025-11-03 | -$48.74M derived: sum of 2 quarters · filed 2025-11-03 | -$102.21M 10-Q · filed 2025-11-03 | -$132.57M derived: sum of 4 quarters · filed 2026-02-23 | ||||
| 2024-06-30 | -$30.11M derived: 10-Q 6 month − 10-Q 3 month · filed 2025-08-04 | -$83.58M 10-Q · filed 2025-08-04 | -$113.94M derived: sum of 3 quarters · filed 2026-02-23 | -$167.49M derived: sum of 4 quarters · filed 2026-02-23 | ||||
| 2024-03-31 | -$53.47M 10-Q · filed 2025-05-05 | -$83.83M derived: sum of 2 quarters · filed 2026-02-23 | -$137.38M derived: sum of 3 quarters · filed 2026-02-23 | -$192.73M derived: sum of 4 quarters · filed 2026-02-23 | ||||
| 2023-12-31 | -$30.36M derived: 10-K 12 month − 10-Q 9 month · filed 2026-02-23 | -$83.91M derived: sum of 2 quarters · filed 2026-02-23 | -$139.26M derived: sum of 3 quarters · filed 2026-02-23 | -$145.08M 10-K · filed 2026-02-23 | ||||
| 2023-09-30 | -$53.55M derived: 10-Q 9 month − 10-Q 6 month · filed 2024-11-12 | -$108.90M derived: sum of 2 quarters · filed 2024-11-12 | -$114.72M 10-Q · filed 2024-11-12 | -$142.28M derived: sum of 4 quarters · filed 2025-02-18 | ||||
| 2023-06-30 | -$55.35M derived: 10-Q 6 month − 10-Q 3 month · filed 2024-08-05 | -$61.17M 10-Q · filed 2024-08-05 | -$88.73M derived: sum of 3 quarters · filed 2025-02-18 | -$111.49M derived: sum of 4 quarters · filed 2025-02-18 | ||||
| 2023-03-31 | -$5.82M 10-Q · filed 2024-05-06 | -$33.38M derived: sum of 2 quarters · filed 2025-02-18 | -$56.14M derived: sum of 3 quarters · filed 2025-02-18 | -$89.68M derived: sum of 4 quarters · filed 2025-02-18 | ||||
| 2022-12-31 | -$27.56M derived: 10-K 12 month − 10-Q 9 month · filed 2025-02-18 | -$50.32M derived: sum of 2 quarters · filed 2025-02-18 | -$83.86M derived: sum of 3 quarters · filed 2025-02-18 | -$116.51M 10-K · filed 2025-02-18 | -$116.51M 10-K · filed 2023-02-28 | |||
| 2022-09-30 | -$22.76M derived: 10-Q 9 month − 10-Q 6 month · filed 2023-11-06 | -$56.30M derived: sum of 2 quarters · filed 2023-11-06 | -$88.95M 10-Q · filed 2023-11-06 | -$88.95M 10-Q · filed 2022-11-07 | -$117.79M derived: sum of 4 quarters · filed 2024-02-23 | |||
| 2022-06-30 | -$33.54M derived: 10-Q 6 month − 10-Q 3 month · filed 2023-08-07 | -$66.19M 10-Q · filed 2023-08-07 | -$66.19M 10-Q · filed 2022-08-09 | -$95.03M derived: sum of 3 quarters · filed 2024-02-23 | -$121.81M derived: sum of 4 quarters · filed 2024-02-23 | |||
| 2022-03-31 | -$32.65M 10-Q · filed 2023-05-09 | -$32.65M 10-Q · filed 2022-05-02 | -$61.49M derived: sum of 2 quarters · filed 2024-02-23 | -$88.27M derived: sum of 3 quarters · filed 2024-02-23 | -$113.66M derived: sum of 4 quarters · filed 2024-02-23 | |||
| 2021-12-31 | -$28.84M derived: 10-K 12 month − 10-Q 9 month · filed 2024-02-23 | -$55.62M derived: sum of 2 quarters · filed 2024-02-23 | -$81.01M derived: sum of 3 quarters · filed 2024-02-23 | -$108.23M 10-K · filed 2024-02-23 | -$108.23M 10-K · filed 2022-03-01 | |||
| 2021-09-30 | -$26.78M derived: 10-Q 9 month − 10-Q 6 month · filed 2022-11-07 | -$52.17M derived: sum of 2 quarters · filed 2022-11-07 | -$79.39M 10-Q · filed 2022-11-07 | -$99.94M derived: sum of 4 quarters · filed 2023-02-28 | ||||
| 2021-06-30 | -$25.39M derived: 10-Q 6 month − 10-Q 3 month · filed 2022-08-09 | -$52.61M 10-Q · filed 2022-08-09 | -$73.16M derived: sum of 3 quarters · filed 2023-02-28 | -$88.90M derived: sum of 4 quarters · filed 2023-02-28 | ||||
| 2021-03-31 | -$27.22M 10-Q · filed 2022-05-02 | -$47.77M derived: sum of 2 quarters · filed 2023-02-28 | -$63.50M derived: sum of 3 quarters · filed 2023-02-28 | -$82.40M derived: sum of 4 quarters · filed 2023-02-28 | ||||
| 2020-12-31 | -$20.55M derived: 10-K 12 month − 10-Q 9 month · filed 2023-02-28 | -$36.29M derived: sum of 2 quarters · filed 2023-02-28 | -$55.18M derived: sum of 3 quarters · filed 2023-02-28 | -$78.46M 10-K · filed 2023-02-28 | ||||
| 2020-09-30 | -$15.73M derived: 10-Q 9 month − 10-Q 6 month · filed 2021-11-08 | -$34.63M derived: sum of 2 quarters · filed 2021-11-08 | -$57.90M 10-Q · filed 2021-11-08 | -$75.47M derived: sum of 4 quarters · filed 2022-03-01 | ||||
| 2020-06-30 | -$18.90M derived: 10-Q 6 month − 10-Q 3 month · filed 2021-08-09 | -$42.17M 10-Q · filed 2021-08-09 | -$59.74M derived: sum of 3 quarters · filed 2022-03-01 | -$70.36M derived: sum of 4 quarters · filed 2022-03-01 | ||||
| 2020-03-31 | -$23.27M 10-Q · filed 2021-05-10 | -$40.84M derived: sum of 2 quarters · filed 2022-03-01 | -$51.47M derived: sum of 3 quarters · filed 2022-03-01 | -$60.15M derived: sum of 4 quarters · filed 2022-03-01 | ||||
| 2019-12-31 | -$17.57M derived: 10-K 12 month − 10-Q 9 month · filed 2022-03-01 | -$28.19M derived: sum of 2 quarters · filed 2022-03-01 | -$36.88M derived: sum of 3 quarters · filed 2022-03-01 | -$46.38M 10-K · filed 2022-03-01 | ||||
| 2019-09-30 | -$10.63M derived: 10-Q 9 month − 10-Q 6 month · filed 2020-11-05 | -$19.31M derived: sum of 2 quarters · filed 2020-11-05 | -$28.81M 10-Q · filed 2020-11-05 | -$38.60M derived: sum of 4 quarters · filed 2021-03-01 | ||||
| 2019-06-30 | -$8.68M derived: 10-Q 6 month − 10-Q 3 month · filed 2020-08-10 | -$18.18M 10-Q · filed 2020-08-10 | -$27.97M derived: sum of 3 quarters · filed 2021-03-01 | -$33.89M derived: sum of 4 quarters · filed 2021-03-01 | ||||
| 2019-03-31 | -$9.50M 10-Q · filed 2020-05-11 | -$19.29M derived: sum of 2 quarters · filed 2021-03-01 | -$25.21M derived: sum of 3 quarters · filed 2021-03-01 | -$32.87M derived: sum of 4 quarters · filed 2021-03-01 | ||||
| 2018-12-31 | -$9.79M derived: 10-K 12 month − 10-Q 9 month · filed 2021-03-01 | -$15.71M derived: sum of 2 quarters · filed 2021-03-01 | -$23.37M derived: sum of 3 quarters · filed 2021-03-01 | -$30.05M 10-K · filed 2021-03-01 | ||||
| 2018-09-30 | -$5.91M derived: 10-Q 9 month − 10-Q 6 month · filed 2019-11-07 | -$13.58M derived: sum of 2 quarters · filed 2019-11-07 | -$20.26M 10-Q · filed 2019-11-07 | -$26.55M derived: sum of 4 quarters · filed 2020-03-12 | ||||
| 2018-06-30 | -$7.67M derived: 10-Q 6 month − 10-Q 3 month · filed 2019-08-08 | -$14.35M 10-Q · filed 2019-08-08 | -$20.64M derived: sum of 3 quarters · filed 2020-03-12 | -$27.09M derived: sum of 4 quarters · filed 2020-03-12 | ||||
| 2018-03-31 | -$6.68M 10-Q · filed 2019-05-09 | -$12.97M derived: sum of 2 quarters · filed 2020-03-12 | -$19.42M derived: sum of 3 quarters · filed 2020-03-12 | -$26.52M derived: sum of 4 quarters · filed 2020-03-12 | ||||
| 2017-12-31 | -$6.29M derived: 10-K 12 month − 10-Q 9 month · filed 2020-03-12 | -$12.74M derived: sum of 2 quarters · filed 2020-03-12 | -$19.84M derived: sum of 3 quarters · filed 2020-03-12 | -$26.47M 10-K · filed 2020-03-12 | ||||
| 2017-09-30 | -$6.45M derived: 10-Q 9 month − 10-Q 6 month · filed 2018-11-09 | -$13.54M derived: sum of 2 quarters · filed 2018-11-09 | -$20.18M 10-Q · filed 2018-11-09 | -$27.40M derived: sum of 4 quarters · filed 2019-03-15 | ||||
| 2017-06-30 | -$7.10M derived: 10-Q 6 month − 10-Q 3 month · filed 2018-08-08 | -$13.73M 10-Q · filed 2018-08-08 | -$20.95M derived: sum of 3 quarters · filed 2019-03-15 | -$25.75M derived: sum of 4 quarters · filed 2019-03-15 | ||||
| 2017-03-31 | -$6.64M 10-Q · filed 2018-05-08 | -$13.85M derived: sum of 2 quarters · filed 2019-03-15 | -$18.66M derived: sum of 3 quarters · filed 2019-03-15 | -$23.97M derived: sum of 4 quarters · filed 2019-03-15 | ||||
| 2016-12-31 | -$7.22M derived: 10-K 12 month − 10-Q 9 month · filed 2019-03-15 | -$12.02M derived: sum of 2 quarters · filed 2019-03-15 | -$17.33M derived: sum of 3 quarters · filed 2019-03-15 | -$21.28M 10-K · filed 2019-03-15 | ||||
| 2016-09-30 | -$4.80M derived: 10-Q 9 month − 10-Q 6 month · filed 2017-11-08 | -$10.12M derived: sum of 2 quarters · filed 2017-11-08 | -$14.06M 10-Q · filed 2017-11-08 | -$16.32M derived: sum of 4 quarters · filed 2018-03-07 | ||||
| 2016-06-30 | -$5.31M derived: 10-Q 6 month − 10-Q 3 month · filed 2017-08-09 | -$9.26M 10-Q · filed 2017-08-09 | -$11.51M derived: sum of 3 quarters · filed 2018-03-07 | -$13.44M derived: sum of 4 quarters · filed 2018-03-07 | ||||
| 2016-03-31 | -$3.95M 10-Q · filed 2017-05-09 | -$6.20M derived: sum of 2 quarters · filed 2018-03-07 | -$8.12M derived: sum of 3 quarters · filed 2018-03-07 | -$10.23M derived: sum of 4 quarters · filed 2018-03-07 | ||||
| 2015-12-31 | -$2.25M derived: 10-K 12 month − 10-Q 9 month · filed 2018-03-07 | -$4.17M derived: sum of 2 quarters · filed 2018-03-07 | -$6.28M derived: sum of 3 quarters · filed 2018-03-07 | -$7.44M 10-K · filed 2018-03-07 | ||||
| 2015-09-30 | -$1.92M derived: 10-Q 9 month − 10-Q 6 month · filed 2016-11-14 | -$4.03M derived: sum of 2 quarters · filed 2016-11-14 | -$5.19M 10-Q · filed 2016-11-14 | |||||
| 2015-06-30 | -$2.11M derived: 10-Q 6 month − 10-Q/A 3 month · filed 2016-08-09 | -$3.27M 10-Q · filed 2016-08-09 | ||||||
| 2015-03-31 | -$1.16M 10-Q/A · filed 2016-08-09 | |||||||
| 2014-12-31 | -$4.60M 10-K · filed 2017-03-07 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Elanco Animal Health Inc (ELAN) | United States | $11.177B | -61.80 |
| ARROWHEAD PHARMACEUTICALS, INC. (ARWR) | United States | $9.331B | -42.28 |
| CYTOKINETICS INC (CYTK) | United States | $9.130B | -11.86 |
| Protagonist Therapeutics, Inc (PTGX) | United States | $8.883B | 95.52 |
| TG THERAPEUTICS, INC. (TGTX) | United States | $8.805B | 19.05 |
| MADRIGAL PHARMACEUTICALS, INC. (MDGL) | United States | $11.859B | -38.17 |
| BIOMARIN PHARMACEUTICAL INC (BMRN) | United States | $11.879B | 151.80 |
| Praxis Precision Medicines, Inc. (PRAX) | United States | $7.884B | -27.60 |
| CORCEPT THERAPEUTICS INC (CORT) | United States | $12.804B | 169.10 |
| Structure Therapeutics Inc. (GPCR) | United States | $7.710B | -53.41 |